SZShuo Zhang

Shuo Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuo Zhang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Total synthesis of the capsular polysaccharide repeating unit towards the development of a glycoconjugate vaccine against Klebsiella pneumoniae ST512

    by Shuo Zhang, OndřEj Daněk, Peter H Seeberger

    Klebsiella pneumoniae ST512 is an emerging multidrug-resistant pathogen whose capsular polysaccharide represents a prime target for vaccine development. Here, we report the first total synthesis of the branched hexasaccharide repeating unit of the K. pneumoniae ST512 CPS, together with four structurally related oligosaccharide analogues. Key synthetic challenges including the stereoselective construction of the 1,2- cis glycosidic linkage on the galacturonic acid core and the inherently low reactivity of elongated oligosaccharide intermediates were addressed employing orthogonally protected building blocks. The resulting library of conjugation-ready oligosaccharides, equipped with aminopentyl linkers, enables glycan microarray-based identification of minimal immunogenic epitopes. This work establishes a robust chemical foundation for the rational development of semi-synthetic glycoconjugate vaccines targeting K. pneumoniae ST512.

  • Selective epimerization of GlcNAc to GalNAc through steady-state tuning under kinetic network control

    by Shuo Zhang, Gino Occhialini, Hayden M. Carder, Frank F. J. de Kleijne, Alison E. Wendlandt

    Complex reaction networks can reach out-of-equilibrium steady states governed by multiple kinetic terms arising from multiple product-determining elementary steps. Here we report the optimization of a four-component ‘square’ kinetic network that allows for selective photochemical epimerization of N-acetylglucosamine (GlcNAc) to N-acetylgalactosamine (GalNAc). Network-level mechanistic studies reveal how changes in reaction conditions lead to high selectivity through kinetic adjustments across multiple steps in the network. Although lacking in molecular detail, this network-scale analysis pinpoints kinetically controlling connections for further interrogation. Subsequent molecular-level mechanistic studies reveal that coordination by a boronic ester co-catalyst alters both the site selectivity of hydrogen-atom abstraction and the diastereoselectivity of hydrogen-atom donation, synergistically favouring the formation of GalNAc over other isomers. The optimal reaction conditions enable access to diverse glycosides and glycans of interest in carbohydrate synthesis. This work further establishes kinetic network control to be a versatile paradigm for selective catalysis in out-of-equilibrium systems.


  • Top Cited Papers

    Detection of interstellar 1-cyanopyrene: A four-ring polycyclic aromatic hydrocarbon

    by Gabi Wenzel, Ilsa R. Cooke, P. Bryan Changala, Edwin A. Bergin, Shuo Zhang, Andrew M. Burkhardt, Alex N. Byrne, Steven B. Charnley, Martin A. Cordiner, Miya Duffy, et al.

    Polycyclic aromatic hydrocarbons (PAHs) are organic molecules containing adjacent aromatic rings. Infrared emission bands show that PAHs are abundant in space, but only a few specific PAHs have been detected in the interstellar medium. We detected 1-cyanopyrene, a cyano-substituted derivative of the related four-ring PAH pyrene, in radio observations of the dense cloud TMC-1, using the Green Bank Telescope. The measured column density of 1-cyanopyrene is ∼ 1 .52×10 12 cm −2 , from which we estimate that pyrene contains up to 0.1% of the carbon in TMC-1. This abundance indicates that interstellar PAH chemistry favors the production of pyrene. We suggest that some of the carbon supplied to young planetary systems is carried by PAHs that originate in cold molecular clouds.


  • Open Access

    Total Syntheses of Conjugation‐Ready Repeating Units of Acinetobacter baumannii AB5075 for Glycoconjugate Vaccine Development

    by Shuo Zhang, Peter H. Seeberger

    Acinetobacter baumannii is an opportunistic pathogen that causes serious nosocomial infections. One of the multidrug‐resistant strains, AB5075, can result in bacteremia, pneumonia and wound infections associated with high morbidity and mortality. The structurally unique glycans on the surface of these bacteria are attractive targets for the development of glycoconjugate vaccines. Here, we report the first total synthesis of the densely functionalized trisaccharide repeating unit of A. baumannii AB5075 as well as two analogues. The construction of 1,2‐cis linkages between the rare sugars relies on a double‐serial inversion strategy. The judicious selection of building blocks and reaction conditions allowed for stereoselective glycosylations, the installation of acetamido groups and the (S)‐3‐hydroxybutanoyl chain.


  • Open Access

    Discovery of Oligosaccharide Antigens for Semi‐Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14**

    by Shuo Zhang, Mauro Sella, Julinton Sianturi, Patricia Priegue, Dacheng Shen, Peter H. Seeberger

    Streptococcus suis bacteria are one of the most serious health problems for pigs and an emerging zoonotic agent in humans working in the swine industry. S. suis bacteria express capsular polysaccharides (CPS) a major bacterial virulence factor that define the serotypes. Oligosaccharides resembling the CPS of S. suis serotypes 2, 3, 9, and 14 have been synthesized, glycans related to serotypes 2 and 9 were placed on glycan array surfaces to screen blood from infected pigs. Lead antigens for the development of semi‐synthetic S. suis serotypes 2 and 9 glycoconjugate veterinary vaccines were identified in this way.


  • Open Access

    Discovery of Oligosaccharide Antigens for Semi‐Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14**

    by Shuo Zhang, Mauro Sella, Julinton Sianturi, Patricia Priegue, Dacheng Shen, Peter H. Seeberger

    Streptococcus suis bacteria are one of the most serious health problems for pigs and an emerging zoonotic agent in humans working in the swine industry. S. suis bacteria express capsular polysaccharides (CPS) a major bacterial virulence factor that define the serotypes. Oligosaccharides resembling the CPS of S. suis serotypes 2, 3, 9, and 14 have been synthesized, glycans related to serotypes 2 and 9 were placed on glycan array surfaces to screen blood from infected pigs. Lead antigens for the development of semi‐synthetic S. suis serotypes 2 and 9 glycoconjugate veterinary vaccines were identified in this way.